Medifast, Inc. (MED) — Financial statements
Income statement, balance sheet, and cash flow for Medifast, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 386↓36.0% | 602↓43.8% | 1,072↓32.9% | 1,599↑4.8% | 1,526 | |
| Cost of Revenue | 111↓29.9% | 158↓46.7% | 296↓35.3% | 458↑15.0% | 398 | |
| Gross Profit | 275↓38.1% | 445↓42.7% | 776↓32.0% | 1,140↑1.1% | 1,128 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 289↓34.5% | 442↓32.0% | 649↓32.0% | 956↑4.9% | 911 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 289↓34.5% | 442↓32.0% | 649↓32.0% | 956↑4.9% | 911 | |
| Total Costs & Expenses | 400↓33.3% | 600↓36.6% | 946↓33.1% | 1,414↑7.9% | 1,310 | |
| Operating Results | ||||||
| Operating Income | -14↓593.8% | 3↓97.7% | 126↓31.6% | 185↓14.5% | 216 | |
| Depreciation & Amortization | 11↓17.4% | 13↓3.1% | 13↑19.4% | 11↑61.2% | 7 | |
| EBITDA | -4↓123.8% | 16↓88.8% | 140↓28.7% | 196↓12.2% | 223 | |
| EBIT | -14↓593.8% | 3↓97.7% | 126↓31.6% | 185↓14.6% | 216 | |
| Interest & Other Income | ||||||
| Net Interest Income | 6↑14.8% | 5↑92.9% | 2↑455.2% | -0.70 | 0.00 | |
| Interest Income | 6↑14.8% | 5↑92.9% | 2 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00↓100.0% | 0.70 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00 | 0.00↓100.0% | 0.05 | 0.00 | |
| Other Income / Expenses | 9↑843.2% | 0.91↓62.0% | 2↑420.6% | -0.75↓567.0% | -0.11 | |
| Income Before Tax | -6↓248.9% | 4↓97.1% | 129↓30.0% | 184↓14.8% | 216 | |
| Income Tax Expense | 13↑668.5% | 2↓94.2% | 29↓27.4% | 40↓22.3% | 52 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -19↓993.0% | 2↓97.9% | 99↓30.8% | 144↓12.5% | 164 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -19↓993.0% | 2↓97.9% | 99↓30.8% | 144↓12.5% | 164 | |
| Bottom-Line Net Income | -19↓993.0% | 2↓97.9% | 99↓30.8% | 144↓12.5% | 164 | |
| EPS (Basic) | -1.70↓994.7% | 0.19↓97.9% | 9.10↓29.0% | 12.82↓8.5% | 14.01 | |
| EPS (Diluted) | -1.70↓994.7% | 0.19↓97.9% | 9.10↓28.5% | 12.73↓8.4% | 13.89 | |
| Weighted Average Shares | 11↑0.5% | 11↑0.4% | 11↓2.8% | 11↓4.4% | 12 | |
| Weighted Average Diluted Shares | 11↑0.2% | 11↑0.4% | 11↓3.1% | 11↓4.5% | 12 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.